Skip to content

Arrow Electronics ARW Global Components — Goodwill Impaired Accumulated Impairment Loss

Other segment segments

Global Ecs
$301.9M0.0%

Other financials

Income statement

See full
Revenue$9.5B+39.0%
Gross profit$1.1B+40.9%
Operating income$361.6M+128%
Net income$235.1M+195%
EPS (diluted)$4.55+201%

Balance sheet

See full
Cash & equivalents$286.5M+23.6%
Total debt$2.5B-13.3%
Total equity$6.7B+13.8%
Total assets$36.0B+68.0%

Cash flow

See full
Operating cash flow$699.8M+99.0%
CapEx$32.1M+28.5%
Free cash flow$667.6M+104%

Valuation

See full
Market cap$11.9B+36.0%
Enterprise value$14.08B+18.9%
P/E16.4×-6.2×
P/S0.4×0.0×

Profitability

See full
Gross margin11.3%-0.2pp
Operating margin3.1%+0.4pp
Net margin2.2%+0.8pp
FCF margin3.6%

Returns & leverage

See full
Return on equity11.5%+4.8pp
Debt / equity0.4×-0.1×
Current ratio1.2×-0.2×

Where this comes from

Reported directly by Arrow Electronics in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.

The official record: Arrow Electronics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrow Electronics's global components — goodwill impaired accumulated impairment loss.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrow Electronics's global components — goodwill impaired accumulated impairment loss?
Arrow Electronics (ARW) reported global components — goodwill impaired accumulated impairment loss of $1.3B in Q1 2026.
How has Arrow Electronics's global components — goodwill impaired accumulated impairment loss changed year-over-year?
Arrow Electronics's global components — goodwill impaired accumulated impairment loss decreased by 0.0% year-over-year, from $1.3B to $1.3B.
What is the long-term trend for Arrow Electronics's global components — goodwill impaired accumulated impairment loss?
Over 4 years (2021 to 2025), Arrow Electronics's global components — goodwill impaired accumulated impairment loss has grown at a 0.2% compound annual growth rate (CAGR), from $5.16B to $5.2B.